Stock Option

Mezzion Pharma Co., Ltd.

140410·KOSDAQ·13 grantsAmendments merged

Shares granted, cumulative
987,500shares
Next lockup release
D-393
2027-09-17

Against the share price

At the 2026-08-18 close
KRW
-5.97%
Shares with a reason to exercise
677,700 shares
2.21% of shares outstanding
Sellable right now
485,700 shares
72% of the shares with a reason to exercise
Unrealized paper gain (to the employees)
₩16.5B

Potential dilution

3.23%Against the 15% cap

Shares by strike price

  • ₩173,80027K shares
  • ₩163,00094K shares
  • ₩145,30010K shares
  • ₩100,90086K shares
  • ₩93,00093K shares
  • ₩64,600Latest price
  • ₩58,00056K shares
  • ₩49,583136K shares
  • ₩41,500132K shares
  • ₩38,957150K shares
  • ₩33,200121K shares
  • ₩23,30083K shares

Below the line (strike < Latest price) sits above the strike price: 678K shares, 69% of the shares still inside their exercise window.

Exercise deadline within a yearD-297Earliest deadline 2027-06-13

The paper gain on 83,200 shares sitting above the strike price — ₩3.4B — disappears unless they are exercised by the deadline. Among the options whose lockup has ended, this is the part whose timing is pinned down.

See every approaching deadline

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩64,6002025-08-14 ~ 2026-08-18
  • Strike ₩38,957150K sharesabove
  • Strike ₩49,583136K sharesabove
  • Strike ₩41,500132K sharesabove
  • Strike ₩33,200121K sharesabove

Recipients by role

988KShares granted
  • Unregistered officer20 people37%
  • Other · unknown77 people63%

Sorted from the relation text written in the filings (97 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.

Shares granted by year

297K
132K
86K
37K
94K
150K
192K
'17
'18
'19
'20
'21
'22
'23
'24
'25

Cumulative grants per recipient

40 named · 25 withheld
Largest holderPeter J. MansoOther · unknown
Top holder 13.7%Top 3 31.4%
RecipientShares, cumulativePaper gain
135,00013.7%₩2.7B
120,00012.2%₩1.2B
55,0005.6%₩330M
50,0005.1%—
50,0005.1%₩1.3B
45,0004.6%₩1B
30,0003.0%—
30,0003.0%₩769.3M
30,0003.0%₩769.3M
22,0002.2%₩115.5M

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.